Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Suri Anish Create: Alert

All | News | Filings
Date FiledTypeDescription
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2023 4 Suri Anish (PRESIDENT AND CSO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 125,500 options to buy @ $3.21, valued at $402.9k
04/04/2022 4 Suri Anish (PRESIDENT AND CSO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Paid exercise price by delivering 7,068 shares @ $4.88, valued at $34.5k
Exercised 16,668 restricted stock units @ $0
03/29/2022 4 Suri Anish (PRESIDENT AND CSO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 82,000 options to buy @ $6.91, valued at $566.6k
Granted 21,333 options to buy @ $5.01, valued at $106.9k
11/17/2021 4 Suri Anish (President and CSO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Sold 8,000 shares @ $18.05, valued at $144.4k
Exercised 8,000 options to buy @ $8.26, valued at $66.1k
11/15/2021 4 Suri Anish (President and CSO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Sold 20,000 shares @ $15.0677, valued at $301.4k
Exercised 20,000 options to buy @ $6.42, valued at $128.4k
10/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/07/2020 4 Suri Anish (President and CSO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Sold 800 shares @ $20.01, valued at $16k
Exercised 800 options to buy @ $6.42, valued at $5.1k
08/05/2020 4 Suri Anish (President and CSO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Sold 5,800 shares @ $20.01, valued at $116.1k
Sold 400 shares @ $20.14, valued at $8.1k
Exercised 2,000 options to buy @ $8.26, valued at $16.5k
Exercised 3,800 options to buy @ $6.42, valued at $24.4k
Exercised 400 options to buy @ $6.42, valued at $2.6k
04/10/2020 4 Suri Anish (President and CSO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Paid exercise price by delivering 5,354 shares @ $0
Granted 50,000 restricted stock units @ $0
Exercised 16,666 restricted stock units @ $0
02/12/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/07/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/08/2019 4 Suri Anish (Chief Scientific Officer) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 150,000 options to buy @ $6.42, valued at $963k
Granted 100,000 options to buy @ $11.54, valued at $1.2M
12/26/2018 4 Suri Anish (Chief Scientific Officer) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Bought 2,000 shares @ $4.37, valued at $8.7k
08/16/2018 4 Suri Anish (Chief Scientific Officer) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 20,000 options to buy @ $8.26, valued at $165.2k
05/16/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy